SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-082229
Filing Date
2022-12-22
Accepted
2022-12-22 16:45:29
Documents
17
Period of Report
2022-12-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170700-8k_dominari.htm   iXBRL 8-K 27355
2 CERTIFICATE OF AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION ea170700ex3-1_dominari.htm EX-3.1 1780
3 PRESS RELEASE, DATED AS OF DECEMBER 22, 2022 ea170700ex99-1_dominari.htm EX-99.1 7906
4 GRAPHIC ex3-1_001.jpg GRAPHIC 94189
5 GRAPHIC ex3-1_002.jpg GRAPHIC 135352
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5294
  Complete submission text file 0001213900-22-082229.txt   539714

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE domh-20221222.xsd EX-101.SCH 3227
8 XBRL LABEL FILE domh-20221222_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE domh-20221222_pre.xml EX-101.PRE 22359
11 EXTRACTED XBRL INSTANCE DOCUMENT ea170700-8k_dominari_htm.xml XML 3711
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Dominari Holdings Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 221482493
SIC: 2834 Pharmaceutical Preparations